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A Parent-of-Origin Effect in Two Families with Retinoblastoma Is
Associated with a Distinct Splice Mutation in the RB1 Gene
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1Institut fu¨r Humangenetik and 2Institut fu¨r Molekularbiologie, Universita¨tsklinikum Essen, Essen, Germany
We have identified a splice-site mutation (IVS6+1GrT) in the RB1 gene, in two unrelated families with incomplete-
penetrance retinoblastoma. Analysis of RNA from white blood cells showed that this mutation causes skipping of
exon 6. Although this deletion results in a frameshift, most carriers of the mutation did not develop retinoblastoma.
Interestingly, the relative abundance of the resultant nonsense messenger RNA varies between members of the same
family and is either similar to or considerably lower than the transcript level of the normal allele. Moreover, variation
of relative transcript levels is associatedwith both the sex of the parent that transmitted themutant allele andphenotypic
expression: All eight carriers with similar abundance of nonsense and normal transcript have received the mutant
allele from their mother, and only one of them has developed retinoblastoma; by contrast, all eight carriers with
reduced abundance of the nonsense transcript have received the mutant allele from their father, and all but two them
have retinoblastoma. After treatment with cycloheximide, the relative abundance of transcripts from paternally in-
herited mutant alleles was partly restored, thus indicating that posttranscriptional mechanisms, rather than transcrip-
tional silencing, are responsible for low levels of mutant messenger RNA.Our data suggest that a specificRB1mutation
can be associated with differential penetrance, on the basis of the sex of the transmitting parent.
Hereditary predisposition to retinoblastoma (MIM
180200) is caused by oncogenic germline mutations in
the RB1 gene (Locus Link accession number L11910).
Heterozygous carriers can show variable phenotypic ex-
pression. This is to be expected, because formation of a
tumor focus depends on a chance second mutation,
which is a rare event that follows a Poisson distribution
(Knudson 1971). Actually, analysis of phenotypic vari-
ation within families has shown that the ratio of mu-
tation carriers with bilateral tumors, with unilateral tu-
mors, and without tumors complies with the predictions
from such a stochastic model (Lohmann et al. 1994). In
most families with retinoblastoma, penetrance is com-
plete, and almost all mutation carriers develop tumors
in both eyes. Typically, retinoblastoma predisposition in
these families is caused by RB1 mutations that cause
premature termination codons in any but the ultimate
and penultimate exons of this gene (Lohmann et al.
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1996). Analysis of constitutional cells from individu-
als who are heterozygous for mutations of this kind has
shown that transcripts from the mutant allele are con-
siderably less abundant than are those from the nor-
mal allele (Dunn et al. 1989). This decreased abundance
parallels findings in other genes and is most probably
due to nonsense-mediated decay, which is a surveillance
mechanism that specifically degrades mutant mRNAs
with premature termination codons 150 nt upstream
from the ultimate exon-exon junction (Culbertson 1999;
Frischmeyer and Dietz 1999; Hentze and Kulozik 1999).
Only a few families with retinoblastoma show incom-
plete penetrance. Most of these families show distinct
RB1 mutations that do not result in premature termi-
nation codons (Sakai et al. 1991; Onadim et al. 1992;
Lohmann et al. 1994; Bremner et al. 1997; Otterson et
al. 1997). Here we report an RB1 splice mutation that,
although resulting in a nonsense transcript, is associated
with incomplete penetrance in two unrelated families
with retinoblastoma. Moreover, in both families, this
mutation is associated with differential penetrance, on
the basis of the sex of the transmitting parent.
Predictive testing for retinoblastoma predisposition
was requested by relatives of a patient with bilateral
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Figure 1 Pedigrees and segregation of IVS61GrT. Blackened symbols denote patients with bilateral retinoblastoma; half-blackened symbols
denote patients with unilateral retinoblastoma. Plus signs () indicate presence of IVS61G; “mt” indicates presence of IVS61T; horizontal bar
indicates individuals investigated by RNA analysis. A, Family G162. The frame encloses the branch of this family that has been described elsewhere
(Czeizel and Gardonyi 1974). B, Family M12487. Individual II-2 died of retinoblastoma and may have had bilateral tumors (half-crosshatched,
half-blackened symbol).
retinoblastoma (G162 V-4; fig. 1A) whose mutation
had been identified in a previous study (Lohmann et
al. 1996). Thereby, we learned that retinoblastoma also
occurred in a distant branch of her family. Our study
was approved by the medical ethics committee of the
Universita¨t Essen, and appropriate informed consent
was obtained from all human subjects and/or their par-
ents. Molecular analyses including members from this
sibship showed the same single-base substitution—
namely, g.45867GrT (also known as “IVS61GrT”)
—with the identical haplotype background, at linked
polymorphic loci. Overall, the family comprises 8 and
5 patients with bilateral and unilateral retinoblastoma,
respectively; moreover,12 heterozygous carriers in this
family have not developed retinoblastoma. We identified
the same mutation with a different haplotype back-
ground (at D13S153, RB1.20 [Yandell and Dryja 1989],
and D13S1307), in a patient from an unrelated family
(M12487 V-1; fig. 1B) who had bilateral retinoblastoma.
At the time of diagnosis, she had, in both eyes, more
than four tumor foci, a number that is typical for pa-
tients from families with complete penetrance. However,
mutation testing and pedigree analysis revealed at least
eight nonpenetrant carriers in her family.
The base substitution that both families share alters
position 1 of a GT-AG intron. The most likely effect of
this mutation is the skipping of exon 6, which comprises
68 bp, and this mutation results in a frameshift and
premature termination codons (the first is expected to
be at codon 188 in exon 7). Similar RB1 mutations are
associated with complete penetrance and bilateral ret-
inoblastoma. Actually, we know of five unrelated pa-
tients with different base substitutions (IVS61GrC
and IVS61GrA; fig. 2A) at the same nucleotide, and
Figure 2 Results of RNA analysis. A, Genomic organization of RB1. Boxes indicate exons; arrowheads indicate location and orientation of
primers that were used for RT-PCR and sequencing. B, Agarose gel electrophoresis of products obtained by RT-PCR with primers c438se and
c1487as followed by PCR with primers c438se and c879as. “C” denotes normal control; “Ø” denotes a negative control. The DNA standard used
was pUC19/MspI. C, Result of sequence analysis of the smaller products from M12487 V-1 and G162 V-7. The first premature termination codon
is created 23 bp downstream from the exons 5–7 junction and is indicated by an asterisk (*). D, Results of quantitative analysis of fluorescent RT-
PCR products obtained with primers c438se and c879as. Boxed numeric values below peaks are the peak integrals as determined by the Genotyper
software; the ratio of individual peak integrals to the grand total is shown to the right of each peak. E, Graph with summary of results of fluorescent
RT-PCR. Each circle indicates the ratio of the mutant peak integral to the grand total and represents the result of a single RT-PCR; vertical bars
indicate the arithmetic means.
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all of those patients have sporadic bilateral retinoblas-
toma (Lohmann et al. 1996 and unpublished data). In
light of this, it is astounding that most carriers of the
IVS61GrT allele developed no tumor. To account for
this, we surmised that this mutation might not result in
a frameshift and premature termination, possibly be-
cause of frame-restoring alternative splicing. To test
this, we extracted total RNA from peripheral-blood leu-
kocytes from mutation carriers with (G162 V-3 and
M12487 V-1) and without (G162 IV-7, G162 IV-8,
G162 IV-10, M12487 III-1, and M12487 IV-3) tumors,
as well as from normal controls. We performed RT-PCR
with primers c438se and c1487as followed by PCR with
primers c438se and c879as (fig. 2A). Agarose gel elec-
trophoresis of PCR products from carriers with retino-
blastoma showed a DNA band of the expected (i.e.,
normal) length and, with considerably less intensity, a
smaller product (fig. 2B). In mutation carriers without
tumors, the normal and smaller bands had equal inten-
sity. Normal controls showed the normal-length band
only. To determine the sequence of these products, we
performed RT-PCR, with primers c438se and c1487as,
on RNA from mutation carriers with and without tu-
mors (M12487 V-1 and G162 V-7, respectively) and one
normal control. To improve separation, we digested the
products with EcoRI prior to electrophoresis. DNA was
recovered from agarose slices containing individual
bands, was amplified by PCR with primers c438se and
c879as, and was sequenced. All normal-length products
showed a normal sequence; all smaller products from
mutation carriers showed the same sequence but without
the 68 bp corresponding to exon 6 (fig. 2C). The first in-
frame stop codon occurs 23 bp downstream from the
exons 5–7 junction. No frame-restoring alteration up-
stream from the skipped exon was identified by sequenc-
ing of RT-PCR products obtained, with primers c66se
and c879as, from RNA from the healthy carrier (M12487
IV-3). To further investigate the differences in the pro-
portion of the mutant transcript between mutation car-
riers with and without tumors, we obtained leukocyte
RNA from additional carriers of the IVS61GrT mu-
tation and from patients with similar mutations (i.e.,
IVS61GrC, IVS61GrA, and a complex substitution
comprising IVS61GrT and K220X; fig. 2A). We per-
formed RT-PCR with primers c438se and c879as includ-
ing a fluorescent label (i.e., FAM) and analyzed the prod-
ucts on a 310 Genetic Analyzer by use of Genescan and
Genotyper software (Applied Biosystems) (fig. 2D). The
relative abundance of the mutant mRNA showed a bi-
modal distribution (fig. 2E): In 8 of 16 carriers of the
IVS61GrT mutation and all patients with similar mu-
tations, the relative proportion of mutant products was
small (mean peak integral of mutant products SD was
of grand total); in the other 8 carriers, mu-13% 4%
tant and normal products had about the same intensity
(mean peak integral of mutant products  SD was
of grand total). Intriguingly, all eight car-47% 5%
riers with similar abundance of nonsense and normal
transcript received the mutant allele from their mother,
whereas all eight carriers with reduced relative abun-
dance of the nonsense transcript received the mutant
allele from their father.
Reduced abundance of nonsense transcripts is not an
unusual finding in heterozygous carriers of mutant alleles.
In many genes, this phenomenon was found to be caused
by nonsense-mediated decay, which is a posttranscrip-
tional surveillance mechanism (Culbertson 1999; Frisch-
meyer and Dietz 1999; Hentze and Kulozik 1999). To
examine if posttranscriptional mechanisms account for
the decreased abundance of the mutant mRNA, we ob-
tained lymphoblastoid cell lines with paternally derived
mutant alleles (from G162 V-3 and M12487 V-1) and a
cell line with a maternally derived mutant allele (from
M12487 IV-3) and incubated them, prior to RNA ex-
traction, with cycloheximide, which is an inhibitor of non-
sense-mediated decay (Carter et al. 1995). In parallel ex-
periments, cell lines were harvested after incubation at
concentrations of 100 mg/ml for 6 h and 8 h, at 500 mg/
ml for 6 h, and without exposure to cycloheximide. We
performed fluorescent RT-PCR with primers c438se and
c879as and found that, compared to untreated cell lines,
the relative abundance of mutant mRNA was increased
in all cell lines that were exposed to cycloheximide. (For
G162 V-3, abundance in untreated cell lines was 13%,
and abundance  SD in treated cell lines was 45%
; for M12487 V-1, abundance in untreated cell lines1.5%
was 7.4%, and abundance SD in treated cell lines was
; for M12487 IV-3, abundance in untreated27% 2.5%
cell lines was 28%, and abundance  SD in treated cell
lines was [all abundances are given as %76% 1%
grand total].) This suggests that the markedly low rel-
ative abundance of nonsense mRNA that is transcribed
from paternally inherited alleles is—at least in part—
due to posttranscriptional mechanisms. After cyclohex-
imide treatment, the relative level of nonsense mRNA
from maternally inherited mutant alleles was also in-
creased, thus indicating that these transcripts are also
subject to RNA surveillance.
We observed that relative transcript abundance and
parental origin are also associated with penetrance: Only
one of the eight carriers with similar abundance of non-
sense and normal transcript developed retinoblastoma,
whereas, among the eight carriers with reduced abun-
dance, all but two are affected. The link between pa-
rental origin and penetrance is still valid if family mem-
bers from whom RNA was not obtained are included.
By pedigree analysis, the parental origin of the mutation
can be resolved for 27 family members (14 patients with
retinoblastoma and 13 unaffected mutation carriers). In
13 of 14 patients with retinoblastoma but in only 4 of
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13 unaffected carriers, the mutant allele is of paternal
origin. This is a very unlikely ( , by Fisher’s ex-P ! .002
act-probability test) observation, if the null hypothesis
of no differential penetrance is assumed. Statistical sig-
nificance ( , by Fisher’s exact-probability test)P ! .00002
is even higher when evaluating the diseased-eye ratio,
which is a parameter that takes into account both pen-
etrance and expressivity (Lohmann et al. 1994): The 17
carriers of paternally inherited mutant alleles have 34
eyes (22 affected and 12 without tumor); among the 10
carriers of maternally inherited mutant alleles, only 1 of
20 eyes is affected.
The association between incomplete penetrance of ret-
inoblastoma and the presence of nonsense transcripts
suggests that this mutant mRNA may have a residual
function. It has been suggested that translation initiation
at internal AUG codons may modulate disease pheno-
types (Chang and Gould 1998). Intriguingly, N-terminal
truncated retinoblastoma proteins (pRbs)—including
p56RB, which may result from translation initiation at
codon 379 (located 528 bp downstream from the de-
letion in the mutant transcript)—may be constitutively
active and thus may have strong growth-suppression po-
tential (Hamel et al. 1992; Antelman et al. 1997). To
identify N-terminal truncated pRbs that result from
translation initiation at internal AUG codons, we ana-
lyzed cytoplasmic and nuclear extracts from lympho-
blastoid cell lines from mutation carriers with (G162 V-
3) and without (G162 IV-7 and G162 IV-10) tumors.
Western blot analyses were performed using a mouse
monoclonal anti-human pRb antibody, G3-245 (recog-
nizing an epitope located at amino acids 332–344 [exon
10]; PharMingen). These experiments demonstrated the
presence of wild type but not of a truncated form of
pRb. We used a second mouse monoclonal anti-pRb
antibody, IF8 (epitope encoded by exons 21–27; Santa
Cruz Biotechnology), but again did not detect any N-
terminal truncated pRb (data not shown).
To our knowledge, differential penetrance of retino-
blastoma, on the basis of the sex of the transmitting
parent, has not previously been reported in offspring. In
particular, this inheritance pattern was not observed in
published analyses of parent-of-origin effects in retino-
blastoma (Munier et al. 1992; Naumova and Sapienza
1994; Seminara and Dryja 1994), thus indicating that
it is not apparent in retinoblastoma as a whole (also see
the Imprinted Gene Catalogue Web site). Nevertheless,
it may be restricted to some rare families. Surveying the
literature, we found that an extended family that was
part of Macklin’s (1960) “Study of Retinoblastoma in
Ohio” also shows differential penetrance: All nine pa-
tients with retinoblastoma received the mutant allele via
the paternal germline (see fig. 4 of Macklin 1960). Re-
ferring to this family, Macklin noted that “the degree of
penetrance varies widely not only in different families
but in different sibships in the same family” (1960, p.
32). In fact, variation between sibships in the same fam-
ily is to be expected if penetrance varies based on the
sex of the transmitting parent.
The inheritance pattern in both the family described
by Macklin (1960) and the families described herein is
similar to that in families with hereditary glomus tumors
and suggests the effect of genomic imprinting (van der
Mey et al. 1989). However, the SDHD gene, which is
mutated in patients with hereditary glomus tumors, did
not show parent-of-origin–specific expression in any of
the normal tissues that were investigated (Baysal et al.
2000). To date, there is no model that clearly explains
the inheritance pattern for hereditary glomus tumors
(Taschner et al. 2001). Likewise, RB1 is not known to
be imprinted (Morison et al. 2001). The families with
the IVS61GrT mutation are no exception, because the
effect of cycloheximide treatment suggests that post-
transcriptional mechanisms, rather than transcriptional
silencing, accounts for the low relative abundance of
transcripts from paternally inherited mutant alleles.
It has been reported that loci in the immediate vicinity
of RB1 show parent-of-origin effects (Kato et al. 1996;
Bhattacharyya et al. 2000). It is tempting to speculate
that the unusual inheritance pattern is not a consequence
of the IVS61GrT mutation but is due to allelic as-
sociation with a mutation at an imprinted locus in cis.
The example of the callipyge phenotype in sheep shows
that a mutation can modify the expression of genes in
cis without altering their imprinting status (Charlier et
al. 2001). However, since the IVS61GrT in the two
families are in phase with distinct alleles at linked poly-
morphic loci, they are not identical by descent, and it is
unlikely that they share a mutation in cis, unless this is
a relatively frequent variant.
It is intriguing that we observed the unusual inheri-
tance pattern only in association with the IVS61GrT
mutation, whereas several carriers with other substitu-
tions at the same nucleotide show sporadic bilateral ret-
inoblastoma. It must be noted, however, that most new
germline mutations in RB1 arise on the paternally de-
rived chromosome (Dryja et al. 1997 and literature cited
therein); consequently, there is a bias against the obser-
vation of new mutations on maternally derived chro-
mosomes. Therefore, a parent-of-origin effect that is as-
sociated with other mutations in RB1 may have gone
undetected.
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